Novonix Limited
NVNXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | -0.24 | 0.43 | -0.11 |
| FCF Yield | -33.41% | -23.20% | -6.22% | -10.44% |
| EV / EBITDA | -3.58 | -5.88 | -13.32 | -21.26 |
| Quality | ||||
| ROIC | -24.45% | -18.76% | -21.21% | -16.26% |
| Gross Margin | 69.76% | 65.02% | -558.56% | 71.73% |
| Cash Conversion Ratio | 0.54 | 0.78 | 0.34 | 0.56 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.60% | 9.70% | -10.93% | 12.78% |
| Free Cash Flow Growth | -26.88% | -86.95% | 73.77% | -340.37% |
| Safety | ||||
| Net Debt / EBITDA | -0.42 | 0.27 | 1.01 | 2.19 |
| Interest Coverage | -15.40 | -16.42 | -30.31 | -32.71 |
| Efficiency | ||||
| Inventory Turnover | 1.28 | 1.41 | 11.24 | 0.92 |
| Cash Conversion Cycle | 588.13 | 246.83 | 252.19 | -18.32 |